Pulmonx Corporation
LUNG
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and preā¦ read more
Healthcare
Medical Devices
5 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$2.60
Price+3.18%
$0.08
1Y
Price
Market Cap
$107.235m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-59.4%
EBITDA Margin-64.9%
Net Profit Margin-38.4%
Free Cash Flow MarginRevenue
$91.664m
+9.4%
1y CAGR+19.8%
3y CAGR+17.6%
5y CAGREarnings
-$56.753m
-0.6%
1y CAGR+1.1%
3y CAGR-4.4%
5y CAGREPS
-$1.41
+2.1%
1y CAGR+3.8%
3y CAGR-1.6%
5y CAGRBook Value
$60.033m
$138.281m
Assets$78.248m
Liabilities$56.564m
DebtDebt to Assets
40.9%
-1x
Debt to EBITDAFree Cash Flow
-$32.619m
+1.1%
1y CAGR+10.9%
3y CAGR+7.4%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company